Hutchison China Meditech Limited Chi-Med to Announce 2016 Final Results (9994V)
February 06 2017 - 2:00AM
UK Regulatory
TIDMHCM
RNS Number : 9994V
Hutchison China Meditech Limited
06 February 2017
Chi-Med to Announce 2016 Final Results
London: Monday, February 6, 2017: Hutchison China MediTech
Limited ("Chi-Med") (AIM/Nasdaq: HCM) will be announcing its final
results for the year ended December 31, 2016 on Monday, March 13,
2017 at 7:00 am Greenwich Mean Time (GMT).
An analyst presentation will be held at 9:00 am GMT (5:00 pm
Hong Kong Time) on the same day at Citigate Dewe Rogerson, 3 London
Wall Buildings, London, EC2M 5SY, UK, which will be webcast via the
company website at www.chi-med.com/investors/event-information/.
The presentation will be available to download before the analyst
presentation begins.
For North America based analysts and investors, Chi-Med will
also host a conference call with Q&A at 9:00 am Eastern
Daylight Time (1:00 pm GMT).
Details of the analyst presentation and conference call dial-in
will be provided in the financial results announcement. A replay
will also be available on the website shortly after each event.
About Chi-Med
Chi-Med is an innovative biopharmaceutical company which
researches, develops, manufactures and sells pharmaceuticals and
healthcare products. Its Innovation Platform, Hutchison MediPharma
Limited, focuses on discovering and developing innovative
therapeutics in oncology and autoimmune diseases for the global
market. Its Commercial Platform manufactures, markets, and
distributes prescription drugs and consumer health products in
China.
Chi-Med is majority owned by the multinational conglomerate CK
Hutchison Holdings Limited (SEHK: 0001). For more information,
please visit: www.chi-med.com.
Contacts
Investor Enquiries
Christian Hogg, CEO +852 2121 8200
International Media Enquiries
Anthony Carlisle, +44 7973 611 888 (Mobile) anthony.carlisle@cdrconsultancy.co.uk
Citigate Dewe Rogerson
U.S. Based Media Enquiries
Brad Miles, BMC Communications +1 (917) 570 7340 (Mobile) bmiles@bmccommunications.com
Susan Duffy, BMC Communications +1 (917) 499 8887 (Mobile) sduffy@bmccommunications.com
Investor Relations
Matt Beck, The Trout Group +1 (917) 415 1750 (Mobile) mbeck@troutgroup.com
David Dible, +44 7967 566 919 (Mobile) david.dible@citigatedr.co.uk
Citigate Dewe Rogerson
Panmure Gordon (UK) Limited
Richard Gray / Andrew Potts +44 (20) 7886 2500
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORUGUGGPUPMGGW
(END) Dow Jones Newswires
February 06, 2017 02:00 ET (07:00 GMT)